|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatitis B and human immunodeficiency virus co-infection显示文摘Hepatitis B and human immunodeficiency virus(HBV and HIV)infection share transmission patterns and risk factors,which explains high prevalence of chronic HBV infection in HIV infected patients.The natural course of HBV disease is altered by the HIV infection with less chance to clear acute HBV infection,faster progression to cirrhosis and higher risk of liver-related death in HIVHBV co-infected patients than in HBV mono-infected ones.HIV infected patients with chronic hepatitis B should be counseled for liver damage and surveillance of chronic hepatitis B should be performed to screen early hepatocellular carcinoma.Noninvasive tools are now available to evaluate liver fibrosis.Isolated hepatitis B core antibodies(anti-HBc)are a good predictive marker of occult HBV infection.Still the prevalence and significance of occult HBV infection is controversial,but its screening may be important in the management of antiretroviral therapy.Vaccination against HBV infection is recommended in non-immune HIV patients.The optimal treatment for almost all HIV-HBV co-infectedpatients should contain tenofovir plus lamivudine or emtricitabine and treatment should not be stopped to avoid HBV reactivation.Long term tenofovir therapy may lead to significant decline in hepatitis B surface Antigen.The emergence of resistant HBV strains may compromise the HBV therapy and vaccine therapy. | Bao-Chau Phung Philippe Sogni Odile Launay | 2014 | World Journal of Gastroenterology2014，20，46： | 6 |
| 2 | Treatment of chronic hepatitis B: adherence and safety显示文摘 | Pol S Sogni P | 2010 | Gastroenterol Clin Biol2010，34，2： | 1 |
| 3 | Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis显示文摘 | Elise Pommaret Ariane Vienne Jérémie H. Lefevre Philippe Sogni Christian Florent Beno?t Desaint Yann Parc | 2013 | Surgical Endoscopy2013，，10： | 1 |
| 4 | Sexual function in women undergoing hemodialytic treatment assessed using the female sexual function index (FSFI) and the somatic inkblot series (SIS) test显示文摘 | Sogni F Zacchero M Parola A | 2008 | Clin Nephrol2008，70，1： | 1 |
| 5 | Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH显示文摘 | Dominique Salmon Firouzé Bani-Sadr Marc-Arthur Loko Hind Stitou Anne Gervais Jacques Durant Eric Rosenthal Yann Quertainmont Karl Barange Daniel Vittecoq Michka Shoai-Tehrani Muriel Alvarez Maria Winnock Jean Claude Trinchet Fran?ois Dabis Philippe Sogni | 2011 | Journal of Hepatology2011，，4： | 1 |
| 6 | Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats 显示文摘 | Sogni P Sabry S Moreau R | 1996 | J Hepatol1996，24，4： | 1 |
| 7 | Aortic hypereactivity to norepine phrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of non-steroidal anti-inflam matory drug coupled with a nitric oxide donor显示文摘 | Lefilliatre P Sogni P Bertrand V | | J Gastroenterol Hepatol0，，： | 1 |
| 8 | Effects of Lipopolysaccharide with cirrhosis显示文摘 | Heller J Sogni P Barriere E | 2000 | J Hepatol2000，33，： | 1 |
| 9 | Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselectiveβ-blocker显示文摘 | Florence Vachiery MD Dr. Richard Moreau MD Dr. Adrian Gadano MD Song Yang MD Phillippe Sogni MD Antoine Hadengue MD Stephane Cailmail Thierry Soupison MD Didier Lebrec MD | 1996 | Digestive Diseases and Sciences1996，，9： | 1 |
| 10 | Dosedeperdent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in tow models of portal hypertension in conscious rats显示文摘 | Pilette C Kirstetter P Sogni P | 1996 | J Gastroenterol Hepatol1996，11，： | 1 |
| 11 | Tezosentan an endothelin receptor antagonist,limits liver injury in endotoxin challenged cirrhotic rats显示文摘 | Urbanowicz W Sogni P Moreau R | 2004 | Gut2004，53，： | 1 |
| 12 | Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer显示文摘 | Sogni F Brausi M Frea B | 2008 | Urology2008，71，5： | 1 |
| 13 | Effects of lipopoly saccharide on TNF-α production hepatic NOS activity and hepatic toxicity in rat with cirrhosis显示文摘 | Heller J Sogni P Barriere E | 2000 | Hepatol2000，33，3： | 1 |
| 14 | Effects of lipopolysaccharide on TNF-α production,hepatic NOS activity and hepatic toxieity in rats with cirrhosis显示文摘 | Heller J Sogni P Barriere E | 2000 | J Hepatol2000，33，3： | 1 |
| 15 | Effects of lipopolysaccharide on TNF- alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis 显示文摘 | Heller J Sogni P Barriere E | 2000 | J Hepatol2000，33，3： | 1 |
| 16 | Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients显示文摘AIM To describe factors associated with treatment failure and frequency of resistance-associated substitutions(RAS).METHODS Human immunodeficiency virus(HIV)/hepatitis C virus(HCV) coinfected patients starting a first direct-acting antiviral(DAA) regimen before February 2016 and included in the French ANRS CO13 HEPAVIH cohort were eligible. Failure was defined as:(1) non-response [HCV-RNA remained detectable during treatment, at end of treatment(EOT)]; and(2) relapse(HCVRNA suppressed at EOT but detectable thereafter). Sequencing analysis was performed to describe prevalence of drug class-specific RAS. Factors associated with failure were determined using logistic regression models.RESULTS Among 559 patients, 77% had suppressed plasma HIV-RNA < 50 copies/mL at DAA treatment initiation, 41% were cirrhotic, and 68% were HCV treatmentexperienced. Virological treatment failures occurred in 22 patients and were mainly relapses(17, 77%) then undefined failures(3, 14%) and non-responses(2, 9%). Mean treatment duration was 16 wk overall. Posttreatment NS3, NS5 A or NS5 B RAS were detected in 10/14 patients with samples available for sequencing analysis. After adjustment for age, sex, ribavirin use, HCV genotype and treatment duration, low platelet count was the only factor significantly associated with a higher risk of failure(OR: 6.5; 95%CI: 1.8-22.6). CONCLUSION Only 3.9% HIV-HCV coinfected patients failed DAA regimens and RAS were found in 70% of those failing. Low platelet count was independently associated with virological failure. | Dominique Salmon Pascale Trimoulet Camille Gilbert Caroline Solas Eva Lafourcade Julie Chas Lionel Piroth Karine Lacombe Christine Katlama Gilles Peytavin Hugues Aumaitre Laurent Alric Franoois Boué Philippe Morlat Isabelle Poizot-Martin Eric Billaud Eric Rosenthal Alissa Naqvi Patrick Miailhes Firouzé Bani-Sadr Laure Esterle Patrizia Carrieri Franoois Dabis Philippe Sogni Linda Wittkop 无 | 2018 | World Journal of Hepatology2018，10，11： | 1 |
| 17 | Aorlic hypereactivity to norepinephrine induced by hpopolysaeeharide in cirrhotic rats:beneficial effects of non-steroidal anti-inflammatory drug coupled with a nitric oxide donor 显示文摘 | Lefilliatre P Sogni P Bertrand V | 2001 | J Gastroenterol Hepatol2001，16，： | 1 |
| 18 | Dose -dependment of a nitric oxide biosynthsis inhibion on hyperdynamic circulation intro models of portal hypertention in conscious rats 显示文摘 | Pilette C Kirstetter P Sogni P | 1996 | J gastroenterol Hopatol1996，11，1： | 1 |
| 19 | Effects of lipopolysaccharide with cirrhosis显示文摘 | Heller J Sogni P Barriere E | 2000 | J Hepatol2000，33，： | 1 |
| 20 | Effects of lipopolysaccharide on TNF- alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis显示文摘 | Heller J Sogni P Barriere E | 2000 | Hepatol2000，33，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员